Cargando…
Valid-NEO: A Multi-Omics Platform for Neoantigen Detection and Quantification from Limited Clinical Samples
SIMPLE SUMMARY: Neoantigens have emerged as highly personalized cancer therapeutic targets in recent years. Numerous studies have reported phenomenal therapeutic efficacy through treatments targeting cancer patient-specific neoantigens. Despite the growing interests, to identify druggable neoantigen...
Autores principales: | Terai, Yuri Laguna, Huang, Chun, Wang, Baoli, Kang, Xiaonan, Han, Jing, Douglass, Jacqueline, Hsiue, Emily Han-Chung, Zhang, Ming, Purohit, Raj, deSilva, Taylor, Wang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909145/ https://www.ncbi.nlm.nih.gov/pubmed/35267551 http://dx.doi.org/10.3390/cancers14051243 |
Ejemplares similares
-
NeoFox: annotating neoantigen candidates with neoantigen features
por: Lang, Franziska, et al.
Publicado: (2021) -
NeoPeptide: an immunoinformatic database of T-cell-defined neoantigens
por: Zhou, Wei-Jun, et al.
Publicado: (2019) -
DeepNeo: a webserver for predicting immunogenic neoantigens
por: Kim, Jeong Yeon, et al.
Publicado: (2023) -
neoANT-HILL: an integrated tool for identification of potential neoantigens
por: Coelho, Ana Carolina M. F., et al.
Publicado: (2020) -
Seq2Neo: A Comprehensive Pipeline for Cancer Neoantigen Immunogenicity Prediction
por: Diao, Kaixuan, et al.
Publicado: (2022)